SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mako Yamada, Mamoru Satoh, Masanori Seimiya, Kazuyuki Sogawa, Sakae Itoga, Takeshi Tomonaga, Fumio Nomura, Combined Proteomic Analysis of Liver Tissue and Serum in Chronically Alcohol-Fed Rats, Alcoholism: Clinical and Experimental Research, 2013, 37,
  2. 2
    Xijun Wang, Aihua Zhang, Hui Sun, Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma, Hepatology, 2013, 57, 5
  3. 3
    Deborah L. Diamond, Alexei L. Krasnoselsky, Kristin E. Burnum, Matthew E. Monroe, Bobbie-Jo Webb-Robertson, Jason E. McDermott, Matthew M. Yeh, Jose Felipe Golib Dzib, Nathan Susnow, Susan Strom, Sean C. Proll, Sarah E. Belisle, David E. Purdy, Angela L. Rasmussen, Kathie-Anne Walters, Jon M. Jacobs, Marina A. Gritsenko, David G. Camp, Renuka Bhattacharya, James D. Perkins, Robert L. Carithers, Iris W. Liou, Anne M. Larson, Arndt Benecke, Katrina M. Waters, Richard D. Smith, Michael G. Katze, Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus–mediated liver disease posttransplantation, Hepatology, 2012, 56, 1
  4. 4
    S. Tamir Rashid, Jonathan D. Humphries, Adam Byron, Ameet Dhar, Janet A. Askari, Julian N. Selley, David Knight, Robert D. Goldin, Mark Thursz, Martin J. Humphries, Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver, Journal of Proteome Research, 2012, 11, 8, 4052

    CrossRef

  5. 5
    Natalia Nieto, Matthias P. Lutolf, Extracellular matrix bioengineering and systems biology approaches in liver disease, Systems and Synthetic Biology, 2011, 5, 1-2, 11

    CrossRef

  6. 6
    Keyur Patel, Joseph E. Lucas, J. Will Thompson, Laura G. Dubois, Hans L. Tillmann, Alexander J. Thompson, Diane Uzarski, Robert M. Califf, Martin A. Moseley, Geoffrey S. Ginsburg, John G. McHutchison, Jeanette J. McCarthy, High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients, Hepatology, 2011, 53, 6
  7. 7
    Loredana Fiorentino, Alessia Vivanti, Michele Cavalera, Valeria Marzano, Maurizio Ronci, Marta Fabrizi, Stefano Menini, Giuseppe Pugliese, Rossella Menghini, Rama Khokha, Renato Lauro, Andrea Urbani, Massimo Federici, Increased tumor necrosis factor α–converting enzyme activity induces insulin resistance and hepatosteatosis in mice, Hepatology, 2010, 51, 1
  8. 8
    Matthew L. Cowan, Tony M. Rahman, Sanjeev Krishna, Proteomic approaches in the search for biomarkers of liver fibrosis, Trends in Molecular Medicine, 2010, 16, 4, 171

    CrossRef

  9. 9
    Chen Ding, Haiming Wei, Rui Sun, Jian Zhang, Zhigang Tian, Hepatocytes proteomic alteration and seroproteome analysis of HBV-transgenic mice, PROTEOMICS, 2009, 9, 1
  10. 10
    Michael G. Katze, Jamie L. Fornek, Robert E. Palermo, Kathie-Anne Walters, Marcus J. Korth, Innate immune modulation by RNA viruses: emerging insights from functional genomics, Nature Reviews Immunology, 2008, 8, 8, 644

    CrossRef

  11. You have free access to this content11
    Ana Ruiz-Garcia, Marival Bermejo, Aaron Moss, Vicente G. Casabo, Pharmacokinetics in Drug Discovery, Journal of Pharmaceutical Sciences, 2008, 97, 2
  12. 12
    Tatsuya Orimo, Hidenori Ojima, Nobuyoshi Hiraoka, Shigeru Saito, Tomoo Kosuge, Tatsuhiko Kakisaka, Hideki Yokoo, Kazuaki Nakanishi, Toshiya Kamiyama, Satoru Todo, Setsuo Hirohashi, Tadashi Kondo, Proteomic profiling reveals the prognostic value of adenomatous polyposis coli–end-binding protein 1 in hepatocellular carcinoma, Hepatology, 2008, 48, 6
  13. 13
    Kin Jip Cheung, Kelly Tilleman, Dieter Deforce, Isabelle Colle, Hans Van Vlierberghe, Proteomics in liver fibrosis is more than meets the eye, European Journal of Gastroenterology & Hepatology, 2008, 20, 5, 450

    CrossRef

  14. 14
    Yupeng He, Wei Duan, Seng-Lai Tan, Emerging host cell targets for hepatitis C therapy, Drug Discovery Today, 2007, 12, 5-6, 209

    CrossRef

  15. 15
    Willi Suter, Improving Decision-Making in Drug Development Using In Vitro Toxicology Screening, International Journal of Pharmaceutical Medicine, 2007, 21, 5, 347

    CrossRef

  16. 16
    Michael G. Katze, Marcus J. Korth, Lost in the world of functional genomics, systems biology, and translational research: Is there life after the Milstein award?, Cytokine & Growth Factor Reviews, 2007, 18, 5-6, 441

    CrossRef

  17. 17
    Russell Bowler, Nichole Reisdorph, Mining the liver proteome for drug targets for sepsis*, Critical Care Medicine, 2007, 35, 10, 2443

    CrossRef

  18. 18
    Deborah L. Diamond, Jon M. Jacobs, Bryan Paeper, Sean C. Proll, Marina A. Gritsenko, Robert L. Carithers, Anne M. Larson, Matthew M. Yeh, David G. Camp, Richard D. Smith, Michael G. Katze, Proteomic profiling of human liver biopsies: Hepatitis C virus–induced fibrosis and mitochondrial dysfunction, Hepatology, 2007, 46, 3
  19. 19
    Enrique Santamaría, Javier Muñoz, Joaquín Fernández-Irigoyen, Jesús Prìeto, Fernando J. Corrales, Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics, Liver International, 2007, 27, 2
  20. 20
    Efsevia Albanis, Scott L. Friedman, Diagnosis of Hepatic Fibrosis in Patients with Chronic Hepatitis C, Clinics in Liver Disease, 2006, 10, 4, 821

    CrossRef